Board Benchmarking Australia Pty Ltd is a limited by shares Australian proprietary company. Located at VIC 3000 since 2014-09-10 the company is, as the updated on 2020-01-21 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2006-03-15 until 2020-01-01. Known company numbers for Board Benchmarking Australia Pty Ltd are as follows: ACN - 116747249, Australian Business Number - 27116747249. Board Benchmarking Australia Pty Ltd has been the company name since 2008-10-10. Their official company name changed on 2005-10-18 to Leblanc Diagnostics Australia Pty Ltd. The company had used this name up until 2008-10-10. This Australian proprietary company was previously located in VIC 3000 (from 2008-08-15 to 2014-09-10), VIC 3186 (from 2008-02-25 to 2008-08-15), VIC 3186 (from 2007-09-28 to 2008-02-25).
| Status | From | To |
|---|---|---|
| Active | 2005-10-18 | current |
| Name | From | To |
|---|---|---|
| Board Benchmarking Australia Pty Ltd | 2008-10-10 | current |
| Leblanc Diagnostics Australia Pty Ltd | 2005-10-18 | 2008-10-10 |
| Location | From | To |
|---|---|---|
| VIC 3000 | 2014-09-10 | current |
| VIC 3000 | 2008-08-15 | 2014-09-10 |
| VIC 3186 | 2008-02-25 | 2008-08-15 |
| VIC 3186 | 2007-09-28 | 2008-02-25 |
| VIC 3000 | 2005-10-19 | 2007-09-28 |
| VIC 3000 | 2005-10-18 | 2005-10-19 |
| Status | From | To |
|---|---|---|
| Registered | 2006-03-15 | 2020-01-01 |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.